9
Importance of the Biomarker Discussion Forum

At the conclusion of the discussion forum, John R. Ball reaffirmed the committee’s goals in convening this event. He noted that the discussion forum provided an opportunity for stakeholders to learn more about the report and enabled the committee to further flesh out the rationale behind their recommendations. Importantly, the committee was also able to hear from the stakeholders affected by the report recommendations. Dr. Ball noted that these discussions were extremely valuable, and he hoped that this setting allowed all stakeholders—including industry representatives and regulators—to have a dialogue about the important issues in biomarker evaluation.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 97
9 Importance of the Biomarker Discussion Forum At the conclusion of the discussion forum, John R. Ball reaffirmed the committee’s goals in convening this event. He noted that the discussion forum provided an opportunity for stakeholders to learn more about the report and enabled the committee to further flesh out the rationale behind their recommendations. Importantly, the committee was also able to hear from the stakeholders affected by the report recommendations. Dr. Ball noted that these discussions were extremely valuable, and he hoped that this setting allowed all stakeholders—including industry representatives and regulators—to have a dialogue about the important issues in bio- marker evaluation. 

OCR for page 97